yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q36959425-B25A633B-224F-404B-8A97-7B26597A46F4
Q36959425-B25A633B-224F-404B-8A97-7B26597A46F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36959425-B25A633B-224F-404B-8A97-7B26597A46F4
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study
P2860
Q36959425-B25A633B-224F-404B-8A97-7B26597A46F4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36959425-B25A633B-224F-404B-8A97-7B26597A46F4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f34b2d50eb9e29d4d58a0d0e57b48d5e6b3930f
P2860
Sustained antiretroviral effect of raltegravir after 96 weeks of combination therapy in treatment-naive patients with HIV-1 infection.